GlassScriptPhysician profile
Brian D Blanton
NPI 1265605372
$1,014.09
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,000 · 2022: $13.85.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $294.15 | 2021 | |
| Astellas Pharma US INC | $147.10 | 2021 | |
| Myriad Genetic Laboratories, INC. | $109.29 | 2021 | |
| Endo Pharmaceuticals INC. | $87.07 | 2021 | |
| Clarus Therapeutics INC. | $81.49 | 2021 | |
| Pfizer INC. | $58.59 | 2021 | |
| Antares Pharma, INC. | $44.77 | 2021 | |
| Janssen Biotech, INC. | $40.78 | 2021 | |
| Myovant Sciences INC. | $37.20 | 2021 | |
| Coloplast Corp | $27.02 | 2021 | |
| 180 Medical, INC. | $25.06 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.11 | 2021 | |
| Boston Scientific Corporation | $13.85 | 2022 | |
| Amgen INC. | $13.22 | 2021 | |
| Allergan, INC. | $12.90 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $2.49 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Blanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.